SCHEMBL30962584

SCHEMBL30962584

COc1nc(Nc2ccc(C3CCN(C)CC3)c(C)c2)ncc1C(=O)Nc1c(Br)cccc1C#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIK1 P57059 2/20 0.44
▸ SIK2 Q9H0K1 2/20 0.44
▸ SIK3 Q9Y2K2 2/20 0.44
▸ TBK1 Q9UHD2 6/20 0.43
▸ JAK2 O60674 2/20 0.43
▸ LCK P06239 2/20 0.43
▸ KDR P35968 1/20 0.43
▸ JAK3 P52333 1/20 0.43
▸ TEK Q02763 1/20 0.43
▸ MAPK14 Q16539 1/20 0.43
▸ WEE1 P30291 1/20 0.42
▸ MAP4K1 Q92918 1/20 0.42
▸ SLC2A1 P11166 1/20 0.41
▸ PKMYT1 Q99640 2/20 0.41
▸ PTK2 Q05397 4/20 0.41
▸ CCNT1 O60563 1/20 0.40
▸ CDK1 P06493 1/20 0.40
▸ CCNB1 P14635 1/20 0.40
▸ CCNA2 P20248 1/20 0.40
▸ CDK2 P24941 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27313755 1.00 SIK1 (0.44) SIK1SIK2SIK3TBK1JAK2
SCHEMBL30962656 0.91 WEE1 (0.49) SIK1SIK2SIK3TBK1JAK2
SCHEMBL30962865 0.91 SIK1 (0.50) SIK1SIK2SIK3LCKKDR
SCHEMBL27313548 0.91 SIK1 (0.50) SIK1SIK2SIK3LCKKDR
SCHEMBL30962787 0.89 WEE1 (0.51) SIK1SIK2SIK3LCKKDR
SCHEMBL27313554 0.89 WEE1 (0.51) SIK1SIK2SIK3LCKKDR
SCHEMBL30962766 0.89 SIK1 (0.54) SIK1SIK2SIK3JAK2LCK
SCHEMBL30962653 0.89 LCK (0.48) SIK1SIK2SIK3TBK1JAK2
SCHEMBL27313569 0.89 LCK (0.48) SIK1SIK2SIK3TBK1JAK2
SCHEMBL30962770 0.87 LCK (0.51) SIK1SIK2SIK3LCKKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback